05 Dec 2024
Debated Bill
Cumberlege Review: Pelvic Mesh

Analysis of the Debated Bill on Pelvic Mesh and the Cumberlege Review

Context and Structure

  • Debate Title: Cumberlege Review: Pelvic Mesh
  • Type: Debated Bill
  • House: House of Commons
  • Main Focus: The debate focused on the implications of surgical mesh implants used to treat pelvic organ prolapse and stress urinary incontinence in women, as examined by the Cumberlege Review.

Key Terminology and Legislation

  • Cumberlege Review: An inquiry into the safety of medicine and medical devices, prominently considering pelvic mesh implants.
  • Pelvic Mesh: A surgical implant used predominately for pelvic organ prolapse (POP) and stress urinary incontinence.
  • “First Do No Harm”: The report title from the Cumberlege Review, highlighting failures in patient safety.

Named Entities and Stakeholders

  • Baroness Julia Cumberlege: Chair of the review, attended the debate.
  • Debbie (constituent): Victim of mesh complications, illustrating the human cost discussed.
  • Baroness Hughes: Released a subsequent report, the Hughes Report, on redress for harmed patients
  • National Health Service (NHS): Implicated in the situation concerning mesh implants.

Numerical Data and Key Dates

  • 21 February 2018: Launch of the Cumberlege Review, by then Secretary of State for Health.
  • 2023: Start of the Patient Safety Commissioner's exploration of redress options.
  • 600 women: Number who provided evidence to the Cumberlege Review.

Policy Discussion and Recommendations

  • Network of Specialist Centres: Nine established centers to address complications.
  • Redress Scheme: The debate highlighted the need for a redress scheme, as recommended by the Cumberlege review, which remains not fully implemented.

Political Positions and Statements

  • Cross-party acknowledgment of the issue's significance.
  • MPs called for greater government accountability and an urgent implementation of recommendations.
  • Criticism on the lack of compensation via the NHS negligence scheme.

Questions Raised and Responses

  • Ministerial Response: Indicated no acceptance of redress recommendations yet, though steps are being made for alternative redress assessment.
  • Compensation: No-fault compensation discussed, with acknowledgment of financial burdens faced by victims.

Departmental and Governmental Context

  • Department of Health and Social Care: Central to responding and implementing recommended actions.
  • Patient Safety Commissioner: Role specified in assessing possibilities for redress.

Potential Impacts and Considerations

  • Volume of Cases: Significant, with further complexity highlighted due to the lack of clear compensation and support structures.
  • Trust in Health Services: At stake, given the prolonged suffering and lack of clear resolutions for victims.

Related Parliamentary Actions

  • Past Debates: Four specific debates on this subject have been acknowledged, indicating ongoing parliamentary interest and concern.
  • Cumberlege Report Recommendations: Continual reference to the need for government accountability to the recommendations made in her report.

The original context highlights stories of real-world implications for citizens like Debbie, driving a rich and emotional debate underscored by technical, medical, and governmental processes and terminologies.

Key Contributions

Original Transcript
Chris Vince
Harlow
Lab/Co-op

I beg to move, That this House has considered pelvic mesh and the Cumberlege Review. Thank you, Mr Stringer, for your chairmanship. I sincerely thank all Members who have come to contribute to this debate. I thank the Minister, my hon.

Friend the Member for Gorton and Denton (Andrew Gwynne), and the shadow Minister, the hon. Member for Sleaford and North Hykeham (Dr Johnson), for attending. I also particularly thank Baroness Cumberlege for coming along to the debate.

In my first MP constituency surgery I met Debbie— I am delighted that Debbie and her husband Ian are here today. Debbie was active. She was into keeping fit and socialising with friends and family but, following her operation to have pelvic mesh inserted, she was forced to give up work.

She now suffers from chronic pain in her hips, pelvis, groin and legs. She often suffers from fatigue. She is unable to exercise. She suffers from incontinence, post-traumatic stress disorder, severe depression and autoimmune disease.

She later found out that the operation to have the mesh inserted was not even necessary. When Debbie had her first operation to have the mesh removed, she was told that it was removed completely, but later found out that was not in fact true.

She was forced to have a second operation, where, again, not all the mesh was removed. Despite winning subsequent court proceedings, she has received no compensation, in part due to the surgeon not being covered by insurance. Debbie’s case shows the barriers for victims of medical negligence.

It took seven years for Debbie’s case to get to court. Part of her concern is that the surgeons operating to remove the mesh are the same doctors who did the initial operation to insert it.

Sir Alec Shelbrooke
Wetherby and Easingwold
Con

This is such an important debate, and many of us in this room have been working on this issue for a very long time. I point the hon. Gentleman to the Government’s review of the NHS. We only have nine centres.

We have to emphasise how important it is that the review addresses the need for more surgeons in these areas. The issues that he is outlining are so common, yet we only have nine centres.

Sir Julian Lewis
New Forest East
Con

I think that often the reason people feel guilt is because they feel that they were not given the necessary information at the beginning and they did not ask for it, but if they had only known, they would not have touched this debatable and deplorable procedure with a bargepole.

Anna Dixon
Shipley
Lab

I thank my hon. Friend for securing this important debate. The NHS has a clinical negligence scheme and it spends a lot of money on lawyers. Does my hon. Friend agree that victims of this particular scandal should, like many others, get no-fault compensation?

And does he think the NHS should look at its clinical negligence scheme and move towards no-fault in order to reduce the spend on lawyers?

Graham Stringer
in the Chair

It looks as though hon. Members do not need reminding that if they wish to catch my eye they should bob, even if they have put in to speak. I call Sir Alec Shelbrooke.

Sir Alec Shelbrooke
14:10

My right hon. Friend has just made an important point. He spoke about the removal of protrusions and seven surgeries. That almost puts a gloss on what has happened. We have all heard from women who have had the surgery and the experience of many of them is that they have been butchered.

It is important to make that clear in this debate, especially for new Members, because we have discussed this in Parliament before: when we think of surgery, we think of any other normal surgery, but this surgery leaves huge amounts of scar tissue and has butchered women in ways that I will not go into now.

That must be recognised when we describe some of the remedials that have happened, mainly because those carrying them out do not really know what they are doing at this stage.

Anna Dixon

I think the right hon. Gentleman makes a very valid point. Obviously, from my professional background, I see myself as fairly well-informed, but the scale of the damage done by this particular implant—the pelvic mesh—is also a shock to me.

It is really timely that new Members are made aware of this issue. Hopefully, we can support any efforts to continue to raise it, and I commend Members who have been in this place for longer on their work to date. I hope that the Minister will reflect on the specific point about research.

As someone with a research background, I absolutely agree with you—I am sorry, Mr Stringer; I meant the right hon. Gentleman—that more effort needs to be put into research, not only on how we might treat such cases in future, but on the remedial effect.

Graham Stringer
in the Chair

I thank the hon. Lady for correcting herself and acknowledging that “you” refers to the Chair. I also remind all hon. Members that interventions should be brief and to the point.

Mrs Sharon Hodgson
Washington and Gateshead South
Lab

Do you want to give some guidance on how long is left, Mr Stringer, so I can cut my speech accordingly?

Graham Stringer
in the Chair

I intend to call the spokesperson for the Liberal Democrats at 2.30 pm.

Mrs Hodgson
14:36

I am grateful to the hon. Lady for covering the recommendations, which I was not able to do. That has relieved me somewhat. We have at last seen some compensation for the victims of Windrush, the infected blood scandal and the Horizon scandal.

Does she agree that it is incumbent on the Government to treat this scandal with the same seriousness, fully accept recommendation 4 and put the redress scheme in place?

Graham Stringer
in the Chair
14:40

Order. The 10-minute time allocation is up. I now move to the official Opposition.

Graham Stringer
in the Chair
14:48

I remind the Minister to leave two minutes at the end for the Member who secured the debate to reply.

Chris Vince
15:00

I thank everyone who has spoken about this vital issue. At its heart, it is about women who have been let down and made to feel guilty because they are the victims. That is just not right. I thank everyone who has taken part in this debate. My right hon.

Friend the Member for New Forest East (Sir Julian Lewis)—today, we are all hon. Friends—rightly said that we have had this debate time and again.

Graham Stringer
in the Chair

Order. Motion lapsed (Standing Order No. 10(6)).

All content derived from official parliamentary records